^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

HLA-A*02 positive

i
Entrez ID:
Related biomarkers:
Associations
Trials
over3years
Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer (clinicaltrials.gov)
P1/2, N=11, Active, not recruiting, Dana-Farber Cancer Institute | Trial primary completion date: Dec 2020 --> Dec 2021
Clinical • Trial primary completion date
|
HLA-A (Major Histocompatibility Complex, Class I, A)
|
HLA-A2 positive • HLA-A*02 positive
|
DPX-E7
over3years
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) (clinicaltrials.gov)
P1, N=14, Active, not recruiting, Nicholas Butowski | Recruiting --> Active, not recruiting | N=30 --> 14
Clinical • Enrollment closed • Enrollment change
|
CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule)
|
HLA-A2 positive • HLA-A*02 positive
|
varlilumab (CDX 1127) • Hiltonol (poly-ICLC) • IMA950